Eligible for therapies that induce transfusion independence?

Redistribution of organ iron via the erythroferrone/hepcidin pathway was demonstrated in transfusion dependent thalassemia patients receiving luspatercept.¹

1. Garbowski MW et al. American Society of Hematolgoy Annual Meeting 2021. Abstract 761.